For instance, the effects of the common overexpression of EGF receptor (EGFR) in cancer cells can be eliminated by the use of luteolin, which decreases the EGFR mRNA via the MAPK inhibition as well as the mTOR and Akt signaling pathways [60]. This evidence concerns the gene EGFR and cancer.